DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20170411

Study on HELLP syndrome - maternal and perinatal outcome

Lakshmi Narayana Kota, Kavitha Garikapati, Prabha Devi Kodey, Gayathri K. B.

Abstract


Background: HELLP Syndrome is a serious obstetric complication in pregnancy characterised by haemolysis, elevated liver enzymes and low platelet count. Incidence is 0.5-0.9% of all pregnancies and in 10-20% of cases with severe preeclampsia and eclampsia. The aim of the study was to study the incidence, different clinical presentations and diagnosis of HELLP syndrome in Pre eclampsia and Eclampsia and to analyze the severity, complications, maternal and perinatal outcome.

Methods: It is a 16 months period retrospective study of 102 cases of preeclampsia and eclampsia admitted in NRIMC and GH in OBGY Department with more than 28 weeks gestation. Of these, 91 cases had preeclampsia and 11 cases had eclampsia. Out of these, 15 cases developed HELLP Syndrome. The available history, clinical data, detailed laboratory investigations were studied and categorized by Mississippi classification for better analysis of complications and outcome in HELLP syndrome.

Results: Of 91 cases of Preeclampsia, 12 cases (13.18%) developed HELLP syndrome and out of 11 cases of Eclampsia, 3 cases (27.27%) had HELLP Syndrome. Majority of the cases belonged to 21-25years age group and were mostly from lower Socio economic status. The present study showed 60% maternal morbidity and 6.6% maternal mortality and the perinatal morbidity and mortality was 46.6% each.

Conclusions: HELLP Syndrome is a severe variant and a dreadful complication of Preeclampsia and Eclampsia, it needs early diagnosis and timely intervention in the form of termination of pregnancy to arrest further progress of pathophysiology leading to complications.


Keywords


Abruption, HELLP Syndrome, IUFD, Pulmonary oedema, PRES, Peripartum hysterectomy, Retinal detachment, Stillbirth

Full Text:

PDF

References


Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: severe consequences of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142:159-67.

Martin JN, Rose CH, Briery CM. Understanding and managing HELLP Syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006;195(4):914-34.

Sowjanya K, Bhavani. Clinical Study on HELLP Syndrome - Maternal and Perinatal Outcome. IOSR Journal of Dental and Medical Sciences. 2016;15(1):71-6.

Ara S, Singh BB. Incidence of HELLP Syndrome in pre-eclampsia and eclampsia and Maternal and Perinatal outcome including Morbidity and Mortality. Indian Journal of Research. 2015;4(7).

Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP Syndrome: subsequent pregnancy outcomes and long term prognosis. Am J Obstet Gynecol. 1995;172(1 Pt 1):125-9.

Isler CM, Rinehart BK, Terrone DA. Maternal mortality associated with HELLP Syndrome. Am J Obs Gyn. 1999;181:924.

Vigil-De Gracia P. Pregnancy complicated by pre eclampsia-eclampsia with HELLP Syndrome. International Journal of Gynecology and Obstetrics. 2001;72(1):17-23.

Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe pre eclampsia: comparative analysis by HELLP Syndrome classification. Am J Obstet Gynecol. 1999;180(6 Pt 1):1373-84.

Liu CM, Chang SD, Cheng PJ, Chao AS.. Comparisons of maternal and perinatal outcomes in Taiwanese women with complete and partial HELLP Syndrome and women with severe Pre eclampsia without HELLP. J Obstet Gynaecol Res. 2006;32(6):550-8.

Visser W, Wallenburg HCS. Temporising management of severe pre eclampsia with and without the HELLP Syndrome. British Journal of Obstet and Gynecology. 1995;102:111-7.

Bassam H, Barton JR, Livingston JC. Risk factors for adverse maternal outcomes among women with HELLP Syndrome. Am J Obstet Gynecol. 2000;183:444.